Form 8-K - Current report:
SEC Accession No. 0001193125-09-067883
Filing Date
2009-03-30
Accepted
2009-03-30 17:17:43
Documents
2
Period of Report
2009-03-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20955
2 LETTER FROM ERNST & YOUNG LLP TO THE SECURITIES AND EXCHANGE COMMISSION dex161.htm EX-16.1 1791
  Complete submission text file 0001193125-09-067883.txt   24475
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 09715100
SIC: 2835 In Vitro & In Vivo Diagnostic Substances